|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.3 CHF | 0.00% |
|
+1.18% | -31.26% |
| Apr. 23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| Feb. 29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Xlife Sciences AG reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CHF 0.372448 million compared to CHF 0.314612 million a year ago. Net loss was CHF 7.7 million compared to CHF 3.2 million a year ago.
Basic loss per share from continuing operations was CHF 1.48.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.26% | 214M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
XLIFE SCIENCES AG 
